Excerpts from DBS report

Analysts: William Simadiputra + Woon Bing Yong

What’s New
• WILMAR to benefit from the success of its well established brand, and after a decade of investments in its distribution channels and production facilities


Share price: 


• Hence, we believe that Wilmar deserves higher a valuation multiple than its CPO plantation peers

• Raise FY21-22F earnings by 7% on stronger topline growth and profitability

• Lift TP to S$6.67, maintain BUY
Deserves higher valuation multiples

Investment Thesis
Wilmar set to reap the benefits after a decade of investments to deliver steady profit performance. Wilmar’s strong earnings growth momentum from both its China and exChina operations should support Wilmar’s share price performance and close the valuation gap with its China subsidiary YKA.

Beside its well-integrated platform, we think Wilmar should trade at higher multiples on better market liquidity than YKA.

Wilmar Nodeforest1.21

Strong food demand to underpin margin uptrend. Wilmar's profitability has been expanding in the last three years and is expected to remain firm from its growing exposure to higher margin branded grocery food segment.

Wilmar is expected to continue to post sublime 2021 earnings performance, mainly driven by YKA in China.

Riding on China's growing food industry. Based on current trends, the COVID-19 situation in China seems to be under control as well as a recovering economy, we expect domestic consumption of oilseeds and other food products to continue benefitting Wilmar.

We used sum-of-the-parts (SOTP) valuation methodology to arrive at a target price (TP) of S$6.67, which implies 21x FY21F PE.

Wilmar should trade at a higher PE multiple on emerging foot print in consumer branded products segment, which helps Wilmar to achieve better margins.

Where we differ:
First mover in capitalising on strong food demand. Wilmar has consistently posted US$300m-400m earnings per quarter supported by its strong presence in China and ex. China food and tropical oil industries.

Key Risks to Our View:
Worse-than-expected second wave of COVID-19 could lead to global recession.

Worse-than-expected fatality rates caused by COVID-19 may lead to a more severe impact on China’s economy and affect Wilmar’s operations in China.

Full report here. 

Share Prices

Counter NameLastChange
AEM Holdings4.280-0.030
Avi-Tech Electronics0.320-
Broadway Ind0.186-0.001
China Sunsine0.440-
Food Empire0.535-
Fortress Minerals0.420-0.025
Geo Energy Res0.440-
Golden Energy0.750-
GSS Energy0.060-
ISDN Holdings0.545-0.005
IX Biopharma0.172-0.002
Jiutian Chemical0.109-
KSH Holdings0.350-
Leader Env0.059-0.001
Medtecs Intl0.189-0.004
Meta Health0.038-0.001
Moya Asia0.055-
Nordic Group0.4050.010
Oxley Holdings0.1770.002
REX International0.2900.010
Sinostar PEC0.230-
Southern Alliance Mining0.620-0.005
Straco Corp.0.400-0.020
Sunpower Group0.4050.005
The Trendlines0.104-
Totm Technologies0.142-0.004
UG Healthcare0.225-
Uni-Asia Group1.060-0.070
Wilmar Intl4.100-
Yangzijiang Shipbldg0.900-0.005

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 2482 guests and no members online